{"ticker": {"uuid": "a1f2d1bb-d861-4274-b693-eb47d1203a1b", "symbol": "TECX", "name": "Tectonic Therapeutic, Inc.", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T12:30:39+00:00", "published_display": "13 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "How (TECX) Movements Inform Risk Allocation Models", "summary": "This article analyzes Avrobio Inc. (NASDAQ: TECX) movements to inform risk allocation models, noting weak near-term sentiment despite strong mid and long-term signals. It outlines institutional trading strategies including long, breakout, and short setups, and provides multi-time", "url": "https://news.stocktradersdaily.com/news_release/43/How_TECX_Movements_Inform_Risk_Allocation_Models_071226031402_1783840442.html", "source_name": "Stock Traders Daily", "published_at": "2026-07-12T03:39:46", "published_display": "12 Jul 2026 03:39", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here's Why We're Not Too Worried About Tectonic Therapeutic's (NASDAQ:TECX) Cash Burn Situation", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxQVjJ2SG05NnlLUXBYVTBQaUJ2eUMwQW1FNS1sSXFiYlRDcHM3OC1LSGI4RmlmLWcyUXVTZFE0ZWhlUzdpclhRY3V4MmkwcU84X3JDZ01RN015RXpUSFFLSk1QVmxnTzNjNFc2Rjc0bWU3MFM4akdnRWR3am9VQ1FMelpDWEZXczgxVWgxdFRMRE53bVE?oc=5", "source_name": "Moomoo", "published_at": "2026-07-09T14:16:21+00:00", "published_display": "09 Jul 2026 14:16", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "We're Hopeful That Tectonic Therapeutic (NASDAQ:TECX) Will Use Its Cash Wisely", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-09T11:12:44+00:00", "published_display": "09 Jul 2026 11:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "If You Invested $1,000 in Tectonic Therapeutic Inc (TECX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMibkFVX3lxTE1LVDgwOWpNT3UwckU2SXBMZWN6VHduTndmel9ROUlpNzRkVkc0TWxSalo4NmRKMDBvQ253a05TMUJQdURlTTRET0h6RTRJcGJ3X01lWVFQQmdkcnVTTFZZOXBwc3AxY2dYeC1ZbFZR?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-04T05:16:32+00:00", "published_display": "04 Jul 2026 05:16", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tectonic Therapeutic (TECX) CSO exercises options and sells 172 shares under 10b5-1 plan", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxOOEcxbFRaXy0ydTBqWWhxVERDOGhtUXlYVG5aclhYMUNCb2l5VmIxQUpfQ2w1bElTSi1EeGs1VG5oX3YxSVNULU5TVjFiS0VybzF4dzJ1Q3VDLURCbVZ1UHdJOXY1X0Zoa005TkF2V0VtUkVYME5YOW9wNENYbVNRV2NJU3lPYWJzVnYtaHI5aHRRbTY0LWtWUEdyZ1ItaEI1ZndZSE92dEJTT05nRTdPWmVfdm5Ic1pvVmc?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Trading Systems Reacting to (TECX) Volatility", "summary": "This article analyzes Avrobio Inc. (NASDAQ: TECX) stock, highlighting strong sentiment across all horizons and a mid-channel oscillation pattern. It details institutional trading strategies, including position trading, momentum breakout, and risk hedging, with specific entry, tar", "url": "https://news.stocktradersdaily.com/news_release/1/Trading_Systems_Reacting_to_TECX_Volatility_070126020602_1782885962.html", "source_name": "Stock Traders Daily", "published_at": "2026-07-01T02:06:00", "published_display": "01 Jul 2026 02:06", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[144] Tectonic Therapeutic, Inc. SEC Filing", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxQOWZfSU5FbUk4MmdGV1AxSmszcVZ3UXRZazh0ekJFY253NzlYLTA5d0k4c2xSMkVmOERNb0NmUy1JZ0VUbDNJMlN1OEQxbk9YcG8zOS1kMXNuREZPZ1h5N3NkOGZ2OHhYeFgyY21kbUhQNlpDRklzb1lEZHctNldnNWh1dnhIUVBNNE94WWxNamp0cS1VdmxRb0dGOEhwLUZ5UTQ4?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tectonic Therapeutic (TECX) CEO logs routine tax withholding on vested RSUs", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxNTGZJTTVxcHFrYXU3bU9LaXFkSUplVVpUUHptMTd5bE8xUjFpQlcybjVHRXY3TURwZW02b2dpQzkwaXZkUnlBRERYMHBzd21MdVZxa3RFWlRvN3d6ejNNSnQ2NWRMUjk0YlN2Z0w5MWs1X2JrT2tWbEUzaFdYWmMxRmRmdW1Yb1JRS0V5RDVTMlhMRkk5V3RUYVVCYlVsanQ1Q1VGX29YcGNmRDFfQXRjMHlzOG1INVRrTmc?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tectonic Therapeutic Completes Enrollment in in Phase 2 Trial of TX45", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/tectonic-therapeutic-completes-enrollment-phase-203042549.html", "source_name": "MT Newswires", "published_at": "2026-06-10T20:30:42+00:00", "published_display": "10 Jun 2026 20:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tectonic Therapeutic Completes Enrollment in TX45 APEX Phase 2 Clinical Trial in PH-HFpEF Patients", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/tectonic-therapeutic-completes-enrollment-tx45-200100955.html", "source_name": "GlobeNewswire", "published_at": "2026-06-10T20:01:00+00:00", "published_display": "10 Jun 2026 20:01", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "(TECX) and the Role of Price-Sensitive Allocations", "summary": "This article provides a quantitative analysis of Avrobio Inc. (NASDAQ: TECX), offering neutral near- and mid-term readings but a long-term positive bias. It details institutional trading strategies including long, breakout, and short positions, along with multi-timeframe signal a", "url": "https://news.stocktradersdaily.com/news_release/90/TECX_and_the_Role_of_Price-Sensitive_Allocations_060826114602_1780976762.html", "source_name": "Stock Traders Daily", "published_at": "2026-06-08T23:46:00", "published_display": "08 Jun 2026 23:46", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Responsive Playbooks and the TECX Inflection", "summary": "This article analyzes Avrobio Inc. (NASDAQ: TECX), identifying a strong near-term sentiment while expecting mid-term neutrality to shift towards a long-term positive bias. It highlights a 76.0:1 risk-reward setup targeting a 22.3% gain with minimal risk and provides three distinc", "url": "https://news.stocktradersdaily.com/news_release/98/Responsive_Playbooks_and_the_TECX_Inflection_052826101601_1780020961.html", "source_name": "Stock Traders Daily", "published_at": "2026-05-28T22:16:00", "published_display": "28 May 2026 22:16", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tectonic Therapeutic Shares Rise After Raymond James Upgrade", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/tectonic-therapeutic-shares-rise-raymond-185129759.html", "source_name": "MT Newswires", "published_at": "2026-05-26T18:51:29+00:00", "published_display": "26 May 2026 18:51", "sentiment": "positive", "sentiment_pct": 58, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Raymond James Upgrades Tectonic Therapeutic to Strong Buy From Outperform, Adjusts PT to $81 From $76", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/raymond-james-upgrades-tectonic-therapeutic-092932114.html", "source_name": "MT Newswires", "published_at": "2026-05-26T09:29:32+00:00", "published_display": "26 May 2026 09:29", "sentiment": "positive", "sentiment_pct": 74, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tectonic Therapeutics: Currently In A Catalyst Vacuum (NASDAQ:TECX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxPckgzc1NoaVZCM1FzT2RlYVlrc2NYMzVEQVhaWjBzZXVpSlpQeEV0Wk1MUDRxQzc0TEhTYXBhLVBCbmdYMW9FM1ItajE2UWxtQXFhQm1MNTFMM1lSaEZScEZ6VXZBWl95MFJndW1SWEJyVnI1UWRsRXdSMXZULTZwblp2MXk4SjNLM21rLTZ5ZWpzanVGdFE?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-05-19T07:00:00+00:00", "published_display": "19 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Understanding the Setup: (TECX) and Scalable Risk", "summary": "This article analyzes Avrobio Inc. (NASDAQ: TECX), noting a neutral near and mid-term outlook but a positive long-term bias. It highlights a significant 78.0:1 risk-reward setup, targeting a 23.7% gain against 0.3% risk, and provides three AI-generated trading strategies (Positio", "url": "https://news.stocktradersdaily.com/news_release/132/Understanding_the_Setup:_TECX_and_Scalable_Risk_051726090802_1779066482.html", "source_name": "Stock Traders Daily", "published_at": "2026-05-17T21:08:00", "published_display": "17 May 2026 21:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Tectonic Therapeutic Announces First Quarter 2026 Financial Results and Recent Business Highlights", "summary": "", "url": "https://news.google.com/rss/articles/CBMi_wFBVV95cUxNcTdXc2FhS2RtaVl6d0JsY3drQ05RdU80Zl96dmZOQl9zWURxZm5paFpiaC1fR0VZY3JXN3lFZ09WT3NwbFVrcjZIRlhxWUVKVE1qWnFJbTVyOGZ0cHk4c0QwVXFJZlhZTG00UEhnMW9Eai1Pa3J5QVotRDVFMEFXeEpxa3g5ODd4T1VzQ0xZak1nU3ktdE1nYjkwekVmMEFUanFxd2tmZ3o1ZzlZQmpJcWNlMHdYRUh1b1kwS3lFU0kzQ1pfOGhjdXNpVlh4WGFQRVJ6UkVvbTVENFJnX05rWFU0Y05jRy1ia2ozdkRZbm5RSDZlSWhId1dicDNwTFk?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The Technical Signals Behind (TECX) That Institutions Follow", "summary": "This article from Stock Traders Daily discusses the technical signals for Avrobio Inc. (NASDAQ: TECX), highlighting a near-term strong sentiment transitioning to mid-term neutrality and long-term positive bias. It presents three AI-generated institutional trading strategies\u2014Posit", "url": "https://news.stocktradersdaily.com/news_release/139/The_Technical_Signals_Behind_TECX_That_Institutions_Follow_050626080001_1778112001.html", "source_name": "Stock Traders Daily", "published_at": "2026-05-06T20:09:02", "published_display": "06 May 2026 20:09", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tectonic Therapeutic (NASDAQ:TECX) Is In A Good Position To Deliver On Growth Plans", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxOYnV0NGdGaEVuQUZ2SlhnZ2FGM0hKS2QwU1duNVVqSG14ZWxSWDR6alpJX3pGcENkNWNob055U1hPZWhJUlR1NUZLNWNkd1h1eURfUU1fOC0ycXdMNW16R2F3V3VGUy1Jai1PYzdsT1M0aEpMQ0hTOVJsN3J6V0hQS3hKeWtOcFEwcW9CYldfbDNvbjlMNC1oUTJTcEtDdlE3N01NOA?oc=5", "source_name": "Market source", "published_at": "2026-05-01T07:00:00+00:00", "published_display": "01 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Tectonic Therapeutic Appoints Jessica Chutter to Board of Directors", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxNUzRCRWptZWRoOWtNamdkQmQ0YURUREVnN0E5cmpDZ0NkaEVLV1JXVWx1emM4MG1ZQ0FsWXN0V2tsLVR0dXJnRXZOaER3Mm1iMnQwSml0c3FDbUNXYmI3cFJEMFhzQ05PblJFTGFpVjZGNXRZM29yNkhzdlB6V2dxYmR3SE5ZRVJURDhmWjQ2aEl2RDB5cmhhbkxUUk1xSXBfa3FjUjZhYjIzTWtTa0FZNkotdnU5eWw3MjFOTlRZVm0xVldIaTFoTFl0MkpUSzRYT19jUTZR?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-04-23T07:00:00+00:00", "published_display": "23 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Tectonic Therapeutic Stock: A $1B+ Opportunity Hinges On Upcoming Phase 2 (NASDAQ:TECX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxQN0pUVVBQa3I4VWN5aVRZdmVIVUt5NWo2UHotV1dfWnF1RVduTUtDRzlINjhnc1NJTFNBZTFORXU0aUhxOGNGa0lVR2NoX0l1c0lYRWZzTzJXRjAxOG85TlA3ZFU0anJSQTlKSms2b0dZcVlZcTNPem11dERsTER4Q0dOVS0wdXN5alY0a0xZcV9DZ3VSU2hwSUFvR3NPVkJWdXhIakJBVjkxc1poRFZF?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-16T07:00:00+00:00", "published_display": "16 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unveiling Bumps: How Tectonic Therapeutic\u2019s Recent Moves Affect the Market", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxOc3RTeDlHSjBGVVJDQlNiNXBUaUVHY1ZZQW03bXd2ejBiSVk1Ti1fOWdMdDVfN1VVYjRGWGJMUWVNZ0NvdTdLcHhXZzBRaDRRRFh4RHJZbXgwRTUzZmdXZjVFb2gyWGNOdmNORVlNZm13al9VeDRqQUNoZXZ2dko1cmlFNmJSd2c?oc=5", "source_name": "timothysykes.com", "published_at": "2026-03-06T08:00:00+00:00", "published_display": "06 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "(TECX) Price Dynamics and Execution-Aware Positioning", "summary": "This article analyzes Avrobio Inc. (NASDAQ: TECX) stock, identifying a mid-channel oscillation pattern and a strong short setup with a 61.1:1 risk-reward ratio. It outlines three AI-generated trading strategies\u2014Position Trading, Momentum Breakout, and Risk Hedging\u2014tailored to dif", "url": "https://news.stocktradersdaily.com/news_release/23/TECX_Price_Dynamics_and_Execution-Aware_Positioning_030126121001_1772385001.html", "source_name": "Stock Traders Daily", "published_at": "2026-03-01T12:10:00", "published_display": "01 Mar 2026 12:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tectonic Therapeutic Announces Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwJBVV95cUxPUGNseENTeERyS0FaQkNZdGM3bTBBUnpYbWxBMFN3MXByUVpUc1hhZndKeFcwY1NiQjBDVDV4RVZtRHB6RUVfWWt0djgyd0wxQndlVDZWZG40QzJkNmhyZjFJc2Frai1DT0szOFpCbDN0TldVXzdxXzM3MTlZQ0hVdzlub0gzNk1PUjhnSFZyMVdXVjd5ckliV0FadkpMMl9jYnNlMlB4UElsZTIwN3RKcmM1MnplcXhEbHU1T2tyaFlGLWZCNDNsMU5qa3EyVkVPZ2E2alVQY2Zhd2lWaEFVMVdLNGMwVlc3a0JWYzFiaXBQN0lyaHB5NV91Vmx3dmx5UmJaSlU2cE9Mb0dqbWNJYkpLUQ?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-02-26T08:00:00+00:00", "published_display": "26 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "(TECX) as a Liquidity Pulse for Institutional Tactics", "summary": "This article provides an AI-driven analysis of Avrobio Inc. (NASDAQ: TECX), highlighting near-term weak sentiment within a broader long-term weak bias, but with mid-term strength. It details specific trading strategies for different risk profiles, including long, breakout, and sh", "url": "https://news.stocktradersdaily.com/news_release/11/TECX_as_a_Liquidity_Pulse_for_Institutional_Tactics_021826104202_1771429322.html", "source_name": "Stock Traders Daily", "published_at": "2026-02-18T10:42:00", "published_display": "18 Feb 2026 10:42", "sentiment": "negative", "sentiment_pct": 38, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Daniel Lochner Bought 70% More Shares In Tectonic Therapeutic", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPWkt0NGotV2dYTlItZml3MWQzREVrNjJvVXRqWmpYOUhvWEp3WHJnTURUTkhodzhMUDRYdndVWjA2RmlHQ215bUczZEltZWFkTkEwOG5Vc3V2WGxELVlVd2k3MU1uUm55SGtPQnFMdjdiTWg1bG5RR18yLU9SX1NCUg?oc=5", "source_name": "Market source", "published_at": "2026-02-14T08:00:00+00:00", "published_display": "14 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "(TECX) Movement as an Input in Quant Signal Sets", "summary": "This article analyzes Avrobio Inc. (NASDAQ: TECX) using quantitative signal sets, noting a near-term strong sentiment challenging persistent mid and long-term weakness. It highlights an exceptional 124.8:1 risk-reward setup targeting a 36.0% gain. The piece also details three AI-", "url": "https://news.stocktradersdaily.com/news_release/52/TECX_Movement_as_an_Input_in_Quant_Signal_Sets_012726082602_1769520362.html", "source_name": "Stock Traders Daily", "published_at": "2026-01-27T08:26:00", "published_display": "27 Jan 2026 08:26", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Liquidity Mapping Around (TECX) Price Events", "summary": "This article provides an AI-driven liquidity mapping analysis for Avrobio Inc. (NASDAQ: TECX), indicating weak sentiment across all time horizons that supports a short bias. It details exceptional risk-reward setups and outlines specific institutional trading strategies including", "url": "https://news.stocktradersdaily.com/news_release/22/Liquidity_Mapping_Around_TECX_Price_Events_011626071802_1768565882.html", "source_name": "Stock Traders Daily", "published_at": "2026-01-16T06:58:35", "published_display": "16 Jan 2026 06:58", "sentiment": "negative", "sentiment_pct": 37, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why (TECX) Price Action Is Critical for Tactical Trading", "summary": "The article analyzes Avrobio Inc. (NASDAQ: TECX) stock, highlighting a near-term weak sentiment within a broader long-term weak bias, despite underlying mid-term strength. It emphasizes a significant 112.3:1 risk-reward short setup, targeting a 33.9% downside with only 0.3% risk.", "url": "https://news.stocktradersdaily.com/news_release/10/Why_TECX_Price_Action_Is_Critical_for_Tactical_Trading_010526061002_1767611402.html", "source_name": "Stock Traders Daily", "published_at": "2026-01-05T06:10:00", "published_display": "05 Jan 2026 06:10", "sentiment": "negative", "sentiment_pct": 19, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tectonic: Strong Buy On Positive Phase 1b TX45 Data And 2026 Inflection Point (TECX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxQMUItWXNsemJtS2IwS3RlaGVsNVlvTFRoRy1qMW1lUEtRQlkwM0dSbGJRc0FsYnhtNHFKelZrekpXMHlqRmktNXVnUjNwWHdVOFhFYWN5eWQwMEhFV09Nc2plbHN2Z2xsV3J0S0lvNTFHRnJXVTI4SW5jMlk3MWx1QzJ0M2lqS1oyRW0wMURFUWs2R01hYkRRVlZRNDk4QnZMNlQzVTRNZ1JkSHVXcmh2S3VfSGZJMWM3?oc=5", "source_name": "Seeking Alpha", "published_at": "2025-11-17T08:00:00+00:00", "published_display": "17 Nov 2025 08:00", "sentiment": "positive", "sentiment_pct": 95, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tectonic Announces $185 Million Private Placement", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxPZlVTVGVWZXJWZDhXUFhLMTQ1OWw4YzdhNm1kN2F0TjFHRWxsYUVHSkZFVXA0YTZUOVUtemVESzk5UlFnQnJzYWJ6ZTVoNm1PQTFiVE5qWDd6RE52ZFlfU2p4QVVWNXh1UEN0eVRILTRxM0ZtbmVKdkxmcTVQNHNYbnFpejFlMjFTa1hGWGRjdU92OVVvc1lCUV9jYk5LcDJJQ0FGNGlqREJzc3BRV0J6MTJfQUFKS2VQU2tGNg?oc=5", "source_name": "GlobeNewswire", "published_at": "2025-02-03T08:00:00+00:00", "published_display": "03 Feb 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why a Watertown biotech opted for a reverse merger over a Series B round", "summary": "Tectonic Therapeutic, a Watertown biotech, decided to pursue a reverse merger instead of a Series B funding round. The CEO discusses the decision to merge with Avrobio, highlighting an unexpected opportunity that arose during their search for new funding. This move comes amidst a", "url": "https://www.bizjournals.com/boston/news/2024/07/12/why-tectonic-chose-reverse-merger.html", "source_name": "The Business Journals", "published_at": "2024-07-12T00:00:00", "published_display": "12 Jul 2024 00:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tectonic Merger Delivers Hope for Gene Therapy Breakthroughs", "summary": "Tectonic Therapeutic, Inc. (TECX) completed a merger with AVROBIO, Inc., securing $130.7 million in private placement funding to support its operations until mid-2027. The company specializes in therapeutic proteins and antibodies targeting GPCRs, with lead programs focusing on G", "url": "https://www.clinicaltrialvanguard.com/news/tectonic-merger-delivers-hope-for-gene-therapy-breakthroughs/", "source_name": "The Clinical Trial Vanguard", "published_at": "2024-06-24T23:39:53", "published_display": "24 Jun 2024 23:39", "sentiment": "positive", "sentiment_pct": 72, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tectonic Therapeutic (TECX) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTFBhblFkdEhqMnl1d0oyZEV4blVYWExMV0VQYzRGXzFINTJXYUxfN1d1cjFaTE9vMkFfRDVmdVVkQkdrVkVLSDNzQ0lzbW1oR08zcFhsSXQ2SUZ0Zw?oc=5", "source_name": "MarketBeat", "published_at": "2024-06-24T13:23:17+00:00", "published_display": "24 Jun 2024 13:23", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tectonic bets on GPCR heart failure drug following reverse merger with Avrobio", "summary": "Tectonic Therapeutic has completed a reverse merger with Avrobio and begun trading on Nasdaq under the ticker 'TECX,' simultaneously raising $130.7 million in a private placement. The new company, with $181 million in cash reserves, is focused on its lead asset TX000045 (TX45) fo", "url": "https://www.pharmaceutical-technology.com/news/tectonic-bets-on-gpcr-heart-failure-drug-following-reverse-merger-with-avrobio/", "source_name": "Pharmaceutical Technology", "published_at": "2024-06-21T00:00:00", "published_display": "21 Jun 2024 00:00", "sentiment": "positive", "sentiment_pct": 76, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tectonic Therapeutic Announces Closing of Merger with AVROBIO as well as Concurrent Private Placement of $130.7 Million", "summary": "Tectonic Therapeutic has completed its merger with AVROBIO and a concurrent private placement of $130.7 million. The combined company, operating as Tectonic Therapeutic, will trade on Nasdaq under the ticker TECX and is expected to have approximately $181 million in cash, cash eq", "url": "https://www.stocktitan.net/news/TECX/tectonic-therapeutic-announces-closing-of-merger-with-avrobio-as-qjehq6sifcdu.html", "source_name": "Stock Titan", "published_at": "2024-06-20T22:39:42", "published_display": "20 Jun 2024 22:39", "sentiment": "positive", "sentiment_pct": 73, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avrobio\u2019s road ends in reverse merger with Tim Springer-backed startup", "summary": "Avrobio, a gene therapy company, has agreed to a reverse merger with Tectonic Therapeutic following struggles with clinical setbacks and a challenging financing market. This deal allows Tectonic to go public and provides some value for Avrobio shareholders, who will hold approxim", "url": "https://finance.yahoo.com/news/avrobio-road-ends-reverse-merger-114200221.html", "source_name": "Market source", "published_at": "2024-01-31T04:52:08", "published_display": "31 Jan 2024 04:52", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AVROBIO and Tectonic Therapeutic to Merge", "summary": "AVROBIO, Inc. and Tectonic Therapeutic, Inc. have announced a definitive merger agreement in an all-stock transaction. The combined company will operate as Tectonic Therapeutic, Inc. and is expected to have approximately $165 million in cash and cash equivalents, allowing it to a", "url": "https://www.citybiz.co/article/514622/avrobio-and-tectonic-therapeutic-to-merge/", "source_name": "citybiz", "published_at": "2024-01-30T18:09:31", "published_display": "30 Jan 2024 18:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "How (TECX) Movements Inform Risk Allocation Models", "summary": "This article analyzes Avrobio Inc. (NASDAQ: TECX) movements to inform risk allocation models, noting weak near-term sentiment despite strong mid and long-term signals. It outlines institutional trading strategies including long, breakout, and short setups, and provides multi-time", "url": "https://news.stocktradersdaily.com/news_release/43/How_TECX_Movements_Inform_Risk_Allocation_Models_071226031402_1783840442.html", "source_name": "Stock Traders Daily", "published_at": "2026-07-12T03:39:46", "published_display": "12 Jul 2026 03:39", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here's Why We're Not Too Worried About Tectonic Therapeutic's (NASDAQ:TECX) Cash Burn Situation", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxQVjJ2SG05NnlLUXBYVTBQaUJ2eUMwQW1FNS1sSXFiYlRDcHM3OC1LSGI4RmlmLWcyUXVTZFE0ZWhlUzdpclhRY3V4MmkwcU84X3JDZ01RN015RXpUSFFLSk1QVmxnTzNjNFc2Rjc0bWU3MFM4akdnRWR3am9VQ1FMelpDWEZXczgxVWgxdFRMRE53bVE?oc=5", "source_name": "Moomoo", "published_at": "2026-07-09T14:16:21+00:00", "published_display": "09 Jul 2026 14:16", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "We're Hopeful That Tectonic Therapeutic (NASDAQ:TECX) Will Use Its Cash Wisely", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-09T11:12:44+00:00", "published_display": "09 Jul 2026 11:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "If You Invested $1,000 in Tectonic Therapeutic Inc (TECX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMibkFVX3lxTE1LVDgwOWpNT3UwckU2SXBMZWN6VHduTndmel9ROUlpNzRkVkc0TWxSalo4NmRKMDBvQ253a05TMUJQdURlTTRET0h6RTRJcGJ3X01lWVFQQmdkcnVTTFZZOXBwc3AxY2dYeC1ZbFZR?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-04T05:16:32+00:00", "published_display": "04 Jul 2026 05:16", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tectonic Therapeutic (TECX) CSO exercises options and sells 172 shares under 10b5-1 plan", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxOOEcxbFRaXy0ydTBqWWhxVERDOGhtUXlYVG5aclhYMUNCb2l5VmIxQUpfQ2w1bElTSi1EeGs1VG5oX3YxSVNULU5TVjFiS0VybzF4dzJ1Q3VDLURCbVZ1UHdJOXY1X0Zoa005TkF2V0VtUkVYME5YOW9wNENYbVNRV2NJU3lPYWJzVnYtaHI5aHRRbTY0LWtWUEdyZ1ItaEI1ZndZSE92dEJTT05nRTdPWmVfdm5Ic1pvVmc?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Trading Systems Reacting to (TECX) Volatility", "summary": "This article analyzes Avrobio Inc. (NASDAQ: TECX) stock, highlighting strong sentiment across all horizons and a mid-channel oscillation pattern. It details institutional trading strategies, including position trading, momentum breakout, and risk hedging, with specific entry, tar", "url": "https://news.stocktradersdaily.com/news_release/1/Trading_Systems_Reacting_to_TECX_Volatility_070126020602_1782885962.html", "source_name": "Stock Traders Daily", "published_at": "2026-07-01T02:06:00", "published_display": "01 Jul 2026 02:06", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[144] Tectonic Therapeutic, Inc. SEC Filing", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxQOWZfSU5FbUk4MmdGV1AxSmszcVZ3UXRZazh0ekJFY253NzlYLTA5d0k4c2xSMkVmOERNb0NmUy1JZ0VUbDNJMlN1OEQxbk9YcG8zOS1kMXNuREZPZ1h5N3NkOGZ2OHhYeFgyY21kbUhQNlpDRklzb1lEZHctNldnNWh1dnhIUVBNNE94WWxNamp0cS1VdmxRb0dGOEhwLUZ5UTQ4?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tectonic Therapeutic (TECX) CEO logs routine tax withholding on vested RSUs", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxNTGZJTTVxcHFrYXU3bU9LaXFkSUplVVpUUHptMTd5bE8xUjFpQlcybjVHRXY3TURwZW02b2dpQzkwaXZkUnlBRERYMHBzd21MdVZxa3RFWlRvN3d6ejNNSnQ2NWRMUjk0YlN2Z0w5MWs1X2JrT2tWbEUzaFdYWmMxRmRmdW1Yb1JRS0V5RDVTMlhMRkk5V3RUYVVCYlVsanQ1Q1VGX29YcGNmRDFfQXRjMHlzOG1INVRrTmc?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tectonic Therapeutic Completes Enrollment in in Phase 2 Trial of TX45", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/tectonic-therapeutic-completes-enrollment-phase-203042549.html", "source_name": "MT Newswires", "published_at": "2026-06-10T20:30:42+00:00", "published_display": "10 Jun 2026 20:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tectonic Therapeutic Completes Enrollment in TX45 APEX Phase 2 Clinical Trial in PH-HFpEF Patients", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/tectonic-therapeutic-completes-enrollment-tx45-200100955.html", "source_name": "GlobeNewswire", "published_at": "2026-06-10T20:01:00+00:00", "published_display": "10 Jun 2026 20:01", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "(TECX) and the Role of Price-Sensitive Allocations", "summary": "This article provides a quantitative analysis of Avrobio Inc. (NASDAQ: TECX), offering neutral near- and mid-term readings but a long-term positive bias. It details institutional trading strategies including long, breakout, and short positions, along with multi-timeframe signal a", "url": "https://news.stocktradersdaily.com/news_release/90/TECX_and_the_Role_of_Price-Sensitive_Allocations_060826114602_1780976762.html", "source_name": "Stock Traders Daily", "published_at": "2026-06-08T23:46:00", "published_display": "08 Jun 2026 23:46", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Responsive Playbooks and the TECX Inflection", "summary": "This article analyzes Avrobio Inc. (NASDAQ: TECX), identifying a strong near-term sentiment while expecting mid-term neutrality to shift towards a long-term positive bias. It highlights a 76.0:1 risk-reward setup targeting a 22.3% gain with minimal risk and provides three distinc", "url": "https://news.stocktradersdaily.com/news_release/98/Responsive_Playbooks_and_the_TECX_Inflection_052826101601_1780020961.html", "source_name": "Stock Traders Daily", "published_at": "2026-05-28T22:16:00", "published_display": "28 May 2026 22:16", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tectonic Therapeutic Shares Rise After Raymond James Upgrade", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/tectonic-therapeutic-shares-rise-raymond-185129759.html", "source_name": "MT Newswires", "published_at": "2026-05-26T18:51:29+00:00", "published_display": "26 May 2026 18:51", "sentiment": "positive", "sentiment_pct": 58, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Raymond James Upgrades Tectonic Therapeutic to Strong Buy From Outperform, Adjusts PT to $81 From $76", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/raymond-james-upgrades-tectonic-therapeutic-092932114.html", "source_name": "MT Newswires", "published_at": "2026-05-26T09:29:32+00:00", "published_display": "26 May 2026 09:29", "sentiment": "positive", "sentiment_pct": 74, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tectonic Therapeutics: Currently In A Catalyst Vacuum (NASDAQ:TECX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxPckgzc1NoaVZCM1FzT2RlYVlrc2NYMzVEQVhaWjBzZXVpSlpQeEV0Wk1MUDRxQzc0TEhTYXBhLVBCbmdYMW9FM1ItajE2UWxtQXFhQm1MNTFMM1lSaEZScEZ6VXZBWl95MFJndW1SWEJyVnI1UWRsRXdSMXZULTZwblp2MXk4SjNLM21rLTZ5ZWpzanVGdFE?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-05-19T07:00:00+00:00", "published_display": "19 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Understanding the Setup: (TECX) and Scalable Risk", "summary": "This article analyzes Avrobio Inc. (NASDAQ: TECX), noting a neutral near and mid-term outlook but a positive long-term bias. It highlights a significant 78.0:1 risk-reward setup, targeting a 23.7% gain against 0.3% risk, and provides three AI-generated trading strategies (Positio", "url": "https://news.stocktradersdaily.com/news_release/132/Understanding_the_Setup:_TECX_and_Scalable_Risk_051726090802_1779066482.html", "source_name": "Stock Traders Daily", "published_at": "2026-05-17T21:08:00", "published_display": "17 May 2026 21:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tectonic Therapeutic Announces First Quarter 2026 Financial Results and Recent Business Highlights", "summary": "", "url": "https://news.google.com/rss/articles/CBMi_wFBVV95cUxNcTdXc2FhS2RtaVl6d0JsY3drQ05RdU80Zl96dmZOQl9zWURxZm5paFpiaC1fR0VZY3JXN3lFZ09WT3NwbFVrcjZIRlhxWUVKVE1qWnFJbTVyOGZ0cHk4c0QwVXFJZlhZTG00UEhnMW9Eai1Pa3J5QVotRDVFMEFXeEpxa3g5ODd4T1VzQ0xZak1nU3ktdE1nYjkwekVmMEFUanFxd2tmZ3o1ZzlZQmpJcWNlMHdYRUh1b1kwS3lFU0kzQ1pfOGhjdXNpVlh4WGFQRVJ6UkVvbTVENFJnX05rWFU0Y05jRy1ia2ozdkRZbm5RSDZlSWhId1dicDNwTFk?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The Technical Signals Behind (TECX) That Institutions Follow", "summary": "This article from Stock Traders Daily discusses the technical signals for Avrobio Inc. (NASDAQ: TECX), highlighting a near-term strong sentiment transitioning to mid-term neutrality and long-term positive bias. It presents three AI-generated institutional trading strategies\u2014Posit", "url": "https://news.stocktradersdaily.com/news_release/139/The_Technical_Signals_Behind_TECX_That_Institutions_Follow_050626080001_1778112001.html", "source_name": "Stock Traders Daily", "published_at": "2026-05-06T20:09:02", "published_display": "06 May 2026 20:09", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tectonic Therapeutic (NASDAQ:TECX) Is In A Good Position To Deliver On Growth Plans", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxOYnV0NGdGaEVuQUZ2SlhnZ2FGM0hKS2QwU1duNVVqSG14ZWxSWDR6alpJX3pGcENkNWNob055U1hPZWhJUlR1NUZLNWNkd1h1eURfUU1fOC0ycXdMNW16R2F3V3VGUy1Jai1PYzdsT1M0aEpMQ0hTOVJsN3J6V0hQS3hKeWtOcFEwcW9CYldfbDNvbjlMNC1oUTJTcEtDdlE3N01NOA?oc=5", "source_name": "Market source", "published_at": "2026-05-01T07:00:00+00:00", "published_display": "01 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tectonic Therapeutic Appoints Jessica Chutter to Board of Directors", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxNUzRCRWptZWRoOWtNamdkQmQ0YURUREVnN0E5cmpDZ0NkaEVLV1JXVWx1emM4MG1ZQ0FsWXN0V2tsLVR0dXJnRXZOaER3Mm1iMnQwSml0c3FDbUNXYmI3cFJEMFhzQ05PblJFTGFpVjZGNXRZM29yNkhzdlB6V2dxYmR3SE5ZRVJURDhmWjQ2aEl2RDB5cmhhbkxUUk1xSXBfa3FjUjZhYjIzTWtTa0FZNkotdnU5eWw3MjFOTlRZVm0xVldIaTFoTFl0MkpUSzRYT19jUTZR?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-04-23T07:00:00+00:00", "published_display": "23 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tectonic Therapeutic Stock: A $1B+ Opportunity Hinges On Upcoming Phase 2 (NASDAQ:TECX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxQN0pUVVBQa3I4VWN5aVRZdmVIVUt5NWo2UHotV1dfWnF1RVduTUtDRzlINjhnc1NJTFNBZTFORXU0aUhxOGNGa0lVR2NoX0l1c0lYRWZzTzJXRjAxOG85TlA3ZFU0anJSQTlKSms2b0dZcVlZcTNPem11dERsTER4Q0dOVS0wdXN5alY0a0xZcV9DZ3VSU2hwSUFvR3NPVkJWdXhIakJBVjkxc1poRFZF?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-16T07:00:00+00:00", "published_display": "16 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unveiling Bumps: How Tectonic Therapeutic\u2019s Recent Moves Affect the Market", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxOc3RTeDlHSjBGVVJDQlNiNXBUaUVHY1ZZQW03bXd2ejBiSVk1Ti1fOWdMdDVfN1VVYjRGWGJMUWVNZ0NvdTdLcHhXZzBRaDRRRFh4RHJZbXgwRTUzZmdXZjVFb2gyWGNOdmNORVlNZm13al9VeDRqQUNoZXZ2dko1cmlFNmJSd2c?oc=5", "source_name": "timothysykes.com", "published_at": "2026-03-06T08:00:00+00:00", "published_display": "06 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "(TECX) Price Dynamics and Execution-Aware Positioning", "summary": "This article analyzes Avrobio Inc. (NASDAQ: TECX) stock, identifying a mid-channel oscillation pattern and a strong short setup with a 61.1:1 risk-reward ratio. It outlines three AI-generated trading strategies\u2014Position Trading, Momentum Breakout, and Risk Hedging\u2014tailored to dif", "url": "https://news.stocktradersdaily.com/news_release/23/TECX_Price_Dynamics_and_Execution-Aware_Positioning_030126121001_1772385001.html", "source_name": "Stock Traders Daily", "published_at": "2026-03-01T12:10:00", "published_display": "01 Mar 2026 12:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tectonic Therapeutic Announces Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwJBVV95cUxPUGNseENTeERyS0FaQkNZdGM3bTBBUnpYbWxBMFN3MXByUVpUc1hhZndKeFcwY1NiQjBDVDV4RVZtRHB6RUVfWWt0djgyd0wxQndlVDZWZG40QzJkNmhyZjFJc2Frai1DT0szOFpCbDN0TldVXzdxXzM3MTlZQ0hVdzlub0gzNk1PUjhnSFZyMVdXVjd5ckliV0FadkpMMl9jYnNlMlB4UElsZTIwN3RKcmM1MnplcXhEbHU1T2tyaFlGLWZCNDNsMU5qa3EyVkVPZ2E2alVQY2Zhd2lWaEFVMVdLNGMwVlc3a0JWYzFiaXBQN0lyaHB5NV91Vmx3dmx5UmJaSlU2cE9Mb0dqbWNJYkpLUQ?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-02-26T08:00:00+00:00", "published_display": "26 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "(TECX) as a Liquidity Pulse for Institutional Tactics", "summary": "This article provides an AI-driven analysis of Avrobio Inc. (NASDAQ: TECX), highlighting near-term weak sentiment within a broader long-term weak bias, but with mid-term strength. It details specific trading strategies for different risk profiles, including long, breakout, and sh", "url": "https://news.stocktradersdaily.com/news_release/11/TECX_as_a_Liquidity_Pulse_for_Institutional_Tactics_021826104202_1771429322.html", "source_name": "Stock Traders Daily", "published_at": "2026-02-18T10:42:00", "published_display": "18 Feb 2026 10:42", "sentiment": "negative", "sentiment_pct": 38, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Daniel Lochner Bought 70% More Shares In Tectonic Therapeutic", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPWkt0NGotV2dYTlItZml3MWQzREVrNjJvVXRqWmpYOUhvWEp3WHJnTURUTkhodzhMUDRYdndVWjA2RmlHQ215bUczZEltZWFkTkEwOG5Vc3V2WGxELVlVd2k3MU1uUm55SGtPQnFMdjdiTWg1bG5RR18yLU9SX1NCUg?oc=5", "source_name": "Market source", "published_at": "2026-02-14T08:00:00+00:00", "published_display": "14 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "(TECX) Movement as an Input in Quant Signal Sets", "summary": "This article analyzes Avrobio Inc. (NASDAQ: TECX) using quantitative signal sets, noting a near-term strong sentiment challenging persistent mid and long-term weakness. It highlights an exceptional 124.8:1 risk-reward setup targeting a 36.0% gain. The piece also details three AI-", "url": "https://news.stocktradersdaily.com/news_release/52/TECX_Movement_as_an_Input_in_Quant_Signal_Sets_012726082602_1769520362.html", "source_name": "Stock Traders Daily", "published_at": "2026-01-27T08:26:00", "published_display": "27 Jan 2026 08:26", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Liquidity Mapping Around (TECX) Price Events", "summary": "This article provides an AI-driven liquidity mapping analysis for Avrobio Inc. (NASDAQ: TECX), indicating weak sentiment across all time horizons that supports a short bias. It details exceptional risk-reward setups and outlines specific institutional trading strategies including", "url": "https://news.stocktradersdaily.com/news_release/22/Liquidity_Mapping_Around_TECX_Price_Events_011626071802_1768565882.html", "source_name": "Stock Traders Daily", "published_at": "2026-01-16T06:58:35", "published_display": "16 Jan 2026 06:58", "sentiment": "negative", "sentiment_pct": 37, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why (TECX) Price Action Is Critical for Tactical Trading", "summary": "The article analyzes Avrobio Inc. (NASDAQ: TECX) stock, highlighting a near-term weak sentiment within a broader long-term weak bias, despite underlying mid-term strength. It emphasizes a significant 112.3:1 risk-reward short setup, targeting a 33.9% downside with only 0.3% risk.", "url": "https://news.stocktradersdaily.com/news_release/10/Why_TECX_Price_Action_Is_Critical_for_Tactical_Trading_010526061002_1767611402.html", "source_name": "Stock Traders Daily", "published_at": "2026-01-05T06:10:00", "published_display": "05 Jan 2026 06:10", "sentiment": "negative", "sentiment_pct": 19, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tectonic: Strong Buy On Positive Phase 1b TX45 Data And 2026 Inflection Point (TECX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxQMUItWXNsemJtS2IwS3RlaGVsNVlvTFRoRy1qMW1lUEtRQlkwM0dSbGJRc0FsYnhtNHFKelZrekpXMHlqRmktNXVnUjNwWHdVOFhFYWN5eWQwMEhFV09Nc2plbHN2Z2xsV3J0S0lvNTFHRnJXVTI4SW5jMlk3MWx1QzJ0M2lqS1oyRW0wMURFUWs2R01hYkRRVlZRNDk4QnZMNlQzVTRNZ1JkSHVXcmh2S3VfSGZJMWM3?oc=5", "source_name": "Seeking Alpha", "published_at": "2025-11-17T08:00:00+00:00", "published_display": "17 Nov 2025 08:00", "sentiment": "positive", "sentiment_pct": 95, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tectonic Announces $185 Million Private Placement", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxPZlVTVGVWZXJWZDhXUFhLMTQ1OWw4YzdhNm1kN2F0TjFHRWxsYUVHSkZFVXA0YTZUOVUtemVESzk5UlFnQnJzYWJ6ZTVoNm1PQTFiVE5qWDd6RE52ZFlfU2p4QVVWNXh1UEN0eVRILTRxM0ZtbmVKdkxmcTVQNHNYbnFpejFlMjFTa1hGWGRjdU92OVVvc1lCUV9jYk5LcDJJQ0FGNGlqREJzc3BRV0J6MTJfQUFKS2VQU2tGNg?oc=5", "source_name": "GlobeNewswire", "published_at": "2025-02-03T08:00:00+00:00", "published_display": "03 Feb 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why a Watertown biotech opted for a reverse merger over a Series B round", "summary": "Tectonic Therapeutic, a Watertown biotech, decided to pursue a reverse merger instead of a Series B funding round. The CEO discusses the decision to merge with Avrobio, highlighting an unexpected opportunity that arose during their search for new funding. This move comes amidst a", "url": "https://www.bizjournals.com/boston/news/2024/07/12/why-tectonic-chose-reverse-merger.html", "source_name": "The Business Journals", "published_at": "2024-07-12T00:00:00", "published_display": "12 Jul 2024 00:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tectonic Merger Delivers Hope for Gene Therapy Breakthroughs", "summary": "Tectonic Therapeutic, Inc. (TECX) completed a merger with AVROBIO, Inc., securing $130.7 million in private placement funding to support its operations until mid-2027. The company specializes in therapeutic proteins and antibodies targeting GPCRs, with lead programs focusing on G", "url": "https://www.clinicaltrialvanguard.com/news/tectonic-merger-delivers-hope-for-gene-therapy-breakthroughs/", "source_name": "The Clinical Trial Vanguard", "published_at": "2024-06-24T23:39:53", "published_display": "24 Jun 2024 23:39", "sentiment": "positive", "sentiment_pct": 72, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tectonic Therapeutic (TECX) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTFBhblFkdEhqMnl1d0oyZEV4blVYWExMV0VQYzRGXzFINTJXYUxfN1d1cjFaTE9vMkFfRDVmdVVkQkdrVkVLSDNzQ0lzbW1oR08zcFhsSXQ2SUZ0Zw?oc=5", "source_name": "MarketBeat", "published_at": "2024-06-24T13:23:17+00:00", "published_display": "24 Jun 2024 13:23", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tectonic bets on GPCR heart failure drug following reverse merger with Avrobio", "summary": "Tectonic Therapeutic has completed a reverse merger with Avrobio and begun trading on Nasdaq under the ticker 'TECX,' simultaneously raising $130.7 million in a private placement. The new company, with $181 million in cash reserves, is focused on its lead asset TX000045 (TX45) fo", "url": "https://www.pharmaceutical-technology.com/news/tectonic-bets-on-gpcr-heart-failure-drug-following-reverse-merger-with-avrobio/", "source_name": "Pharmaceutical Technology", "published_at": "2024-06-21T00:00:00", "published_display": "21 Jun 2024 00:00", "sentiment": "positive", "sentiment_pct": 76, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tectonic Therapeutic Announces Closing of Merger with AVROBIO as well as Concurrent Private Placement of $130.7 Million", "summary": "Tectonic Therapeutic has completed its merger with AVROBIO and a concurrent private placement of $130.7 million. The combined company, operating as Tectonic Therapeutic, will trade on Nasdaq under the ticker TECX and is expected to have approximately $181 million in cash, cash eq", "url": "https://www.stocktitan.net/news/TECX/tectonic-therapeutic-announces-closing-of-merger-with-avrobio-as-qjehq6sifcdu.html", "source_name": "Stock Titan", "published_at": "2024-06-20T22:39:42", "published_display": "20 Jun 2024 22:39", "sentiment": "positive", "sentiment_pct": 73, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avrobio\u2019s road ends in reverse merger with Tim Springer-backed startup", "summary": "Avrobio, a gene therapy company, has agreed to a reverse merger with Tectonic Therapeutic following struggles with clinical setbacks and a challenging financing market. This deal allows Tectonic to go public and provides some value for Avrobio shareholders, who will hold approxim", "url": "https://finance.yahoo.com/news/avrobio-road-ends-reverse-merger-114200221.html", "source_name": "Market source", "published_at": "2024-01-31T04:52:08", "published_display": "31 Jan 2024 04:52", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AVROBIO and Tectonic Therapeutic to Merge", "summary": "AVROBIO, Inc. and Tectonic Therapeutic, Inc. have announced a definitive merger agreement in an all-stock transaction. The combined company will operate as Tectonic Therapeutic, Inc. and is expected to have approximately $165 million in cash and cash equivalents, allowing it to a", "url": "https://www.citybiz.co/article/514622/avrobio-and-tectonic-therapeutic-to-merge/", "source_name": "citybiz", "published_at": "2024-01-30T18:09:31", "published_display": "30 Jan 2024 18:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T12:30:39+00:00", "published_display": "13 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 88, "total_relevant": 46, "sentiment_summary": {"positive": 12, "negative": 5, "neutral": 29, "score": 54, "total": 46, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 79, "events": [{"event": "general", "label": "Market update", "weight": 13.7, "count": 23}, {"event": "earnings", "label": "Earnings", "weight": 4.4, "count": 10}, {"event": "deals", "label": "Deals and strategy", "weight": 3.3, "count": 6}, {"event": "liquidity", "label": "Balance sheet", "weight": 2.2, "count": 4}, {"event": "analyst", "label": "Analyst action", "weight": 1.1, "count": 2}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}], "positive_events": 12, "negative_events": 5}, "market_context": {"has_market_context": true, "latest_close": 34.37, "latest_week": "2026-07-10", "one_week_move": -9.4, "four_week_move": 13.5, "twelve_week_move": 16.5, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 0.191698, "market_dynamics_buy_signal": false, "relative_strength": 23.553813, "fair_value_gap": 47.4, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "undecided", "expectation_probability": 49.9023, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-9.4% over one week, +13.5% over four weeks, trend active, and materially above fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 62, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Stock Traders Daily", "count": 11}, {"label": "Market source", "count": 8}, {"label": "Stock Titan", "count": 5}, {"label": "GlobeNewswire", "count": 5}, {"label": "simplywall.st", "count": 3}, {"label": "MT Newswires", "count": 3}, {"label": "Seeking Alpha", "count": 3}, {"label": "Moomoo", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 38}, {"label": "Industry context", "count": 8}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 23}, {"label": "Earnings", "count": 10}, {"label": "Deals and strategy", "count": 6}, {"label": "Balance sheet", "count": 4}, {"label": "Analyst action", "count": 2}, {"label": "Guidance", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "54/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "79/100 classification confidence."}, {"label": "Company focus", "value": "38", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "3", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "-9.4% over one week, +13.5% over four weeks, trend active, and materially above fair value."}, {"label": "Latest direct headline", "value": "Negative", "tone": "negative", "text": "How (TECX) Movements Inform Risk Allocation Models"}], "updated_at": "2026-07-16T07:05:13.491292+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}